NCT05076851 2021-10-13Neoadjuvant Therapy With Proxalutamide Combined With Androgen Deprivation Therapy（ADT）for High Risk Prostate CancerThe Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolPhase 2 Unknown2 enrolled